Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NTP Radioisotopes
Pretoria, Gauteng, South Africantp.co.za ↗
- Ownership
- Private
- Employees
- ~400
- Development stage
- Other
01
Overview
NTP is a globally leading producer of medical radioisotopes like molybdenum-99 (Mo-99), with a significant share of global supply; its radiopharmaceuticals are used in over 40 million diagnostic studies a year and for therapies including for cancer and thyroid disorders
- Therapeutic areas
- OncologyOther
- Modalities
- RadiopharmaceuticalSmall molecule
- Industry
- Biotech
02
Partnerships
Lantheus Medical ImagingGE HealthcareMallinckrodt PharmaceuticalsNihon Medi-PhysicsJubilant DraxImageIBA Molecular ImagingHTA Co. LtdSamyoung UnitechEczacıbaşı-Monrol groupICPO Foundation (Theranostics, education)
Beyond the preview
Go deeper on NTP Radioisotopes.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NTP Radioisotopes.